Guggenheim Capital LLC Purchases 4,047 Shares of BlackRock Health Sciences Trust (NYSE:BME)

Guggenheim Capital LLC boosted its position in BlackRock Health Sciences Trust (NYSE:BME) by 43.3% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 13,403 shares of the company’s stock after acquiring an additional 4,047 shares during the period. Guggenheim Capital LLC’s holdings in BlackRock Health Sciences Trust were worth $561,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the company. Oppenheimer & Co. Inc. boosted its holdings in shares of BlackRock Health Sciences Trust by 6.0% during the first quarter. Oppenheimer & Co. Inc. now owns 6,271 shares of the company’s stock worth $263,000 after purchasing an additional 355 shares during the period. LPL Financial LLC increased its holdings in BlackRock Health Sciences Trust by 12.5% during the 1st quarter. LPL Financial LLC now owns 69,587 shares of the company’s stock valued at $2,913,000 after purchasing an additional 7,740 shares during the period. Cornerstone Advisory LLC raised its position in BlackRock Health Sciences Trust by 17.4% during the 1st quarter. Cornerstone Advisory LLC now owns 85,260 shares of the company’s stock valued at $3,569,000 after purchasing an additional 12,639 shares during the last quarter. Arete Wealth Advisors LLC purchased a new stake in BlackRock Health Sciences Trust in the 1st quarter worth approximately $509,746,000,000. Finally, Simplicity Solutions LLC bought a new stake in shares of BlackRock Health Sciences Trust in the 1st quarter worth approximately $598,000.

BlackRock Health Sciences Trust Stock Performance

Shares of BlackRock Health Sciences Trust stock opened at $39.64 on Thursday. The business has a 50 day moving average of $40.02 and a 200 day moving average of $40.75. BlackRock Health Sciences Trust has a 52 week low of $38.27 and a 52 week high of $45.50.

BlackRock Health Sciences Trust Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 15th will be issued a $0.213 dividend. The ex-dividend date is Thursday, September 14th. This represents a $2.56 annualized dividend and a yield of 6.45%.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.